• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型喹唑啉衍生物的设计、合成与抗肿瘤活性。

Design, Synthesis, and Antitumor Activity of Novel Quinazoline Derivatives.

机构信息

School of Chemical Engineering, The Key Laboratory for Surface Engineering and Remanufacturing in Shaanxi Province, Xi'an University, Xi'an 710065, China.

School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an 710062, China.

出版信息

Molecules. 2017 Sep 28;22(10):1624. doi: 10.3390/molecules22101624.

DOI:10.3390/molecules22101624
PMID:28956845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6151509/
Abstract

In an attempt to explore a new class of epidermal growth factor receptor (EGFR) inhibitors, novel 4-stilbenylamino quinazoline derivatives were synthesized through a Dimorth rearrangement reaction and characterized via IR, ¹H-NMR, C-NMR, and HRMS. Methoxyl, methyl, halogen, and trifluoromethyl groups on stilbeneamino were detected. These synthesized compounds were evaluated for antitumor activity in vitro against eight human tumor cell lines with an MTS assay. Most synthesized compounds exhibited more potent activity (IC = ~2.0 μM) than gefitinib (IC > 10.0 μM) against the A431, A549, and BGC-823 cell lines. Docking methodology of compound 6c and 6i binding into the ATP site of EGFR was carried out. The results showed that fluorine and trifluoromethyl played an important role in efficient cell activity.

摘要

为了探索新型表皮生长因子受体 (EGFR) 抑制剂,我们通过Dimorth 重排反应合成了新型 4-二苯乙烯基氨基喹唑啉衍生物,并通过 IR、1H-NMR、C-NMR 和高分辨质谱进行了表征。检测到二苯乙烯基氨基上的甲氧基、甲基、卤素和三氟甲基。采用 MTS 法测定了这些合成化合物对 8 个人类肿瘤细胞系的体外抗肿瘤活性。大多数合成化合物对 A431、A549 和 BGC-823 细胞系的活性(IC = ~2.0 μM)强于吉非替尼(IC > 10.0 μM)。对化合物 6c 和 6i 与 EGFR 的 ATP 结合部位进行了对接方法研究。结果表明,氟和三氟甲基在高效细胞活性中起着重要作用。

相似文献

1
Design, Synthesis, and Antitumor Activity of Novel Quinazoline Derivatives.新型喹唑啉衍生物的设计、合成与抗肿瘤活性。
Molecules. 2017 Sep 28;22(10):1624. doi: 10.3390/molecules22101624.
2
Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.以表皮生长因子受体为靶点的喹唑啉和吡啶并[2,3-d]嘧啶衍生物的设计、合成、抗肿瘤活性及分子模拟。
Eur J Med Chem. 2016 Aug 8;118:276-89. doi: 10.1016/j.ejmech.2016.04.026. Epub 2016 Apr 20.
3
Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.一系列具有喹唑啉骨架的新型4-苯胺基喹唑啉衍生物的开发:设计、合成、表皮生长因子受体激酶抑制功效及体外抗癌活性评估
Eur J Med Chem. 2017 Sep 29;138:669-688. doi: 10.1016/j.ejmech.2017.07.005. Epub 2017 Jul 4.
4
Novel morpholin-3-one fused quinazoline derivatives as EGFR tyrosine kinase inhibitors.新型吗啉-3-酮稠合喹唑啉衍生物作为表皮生长因子受体酪氨酸激酶抑制剂
Bioorg Med Chem Lett. 2016 Mar 15;26(6):1571-1575. doi: 10.1016/j.bmcl.2016.02.009. Epub 2016 Feb 4.
5
Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study.设计、合成及新型喹唑啉衍生物的生物评价作为潜在的抗肿瘤药物:分子对接研究。
Eur J Med Chem. 2010 Sep;45(9):4188-98. doi: 10.1016/j.ejmech.2010.06.013. Epub 2010 Jun 16.
6
Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors.设计、合成、具有 2,3-二氢吲哚或 1,2,3,4-四氢喹啉的喹唑啉衍生物的抗增殖活性和对接研究作为潜在的 EGFR 抑制剂。
Eur J Med Chem. 2018 Jun 25;154:29-43. doi: 10.1016/j.ejmech.2018.05.006. Epub 2018 May 9.
7
Discovery of 6-substituted 4-anilinoquinazolines with dioxygenated rings as novel EGFR tyrosine kinase inhibitors.发现具有双氧代环的 6-取代 4-苯胺基喹唑啉类化合物作为新型 EGFR 酪氨酸激酶抑制剂。
Bioorg Med Chem Lett. 2012 Sep 15;22(18):5870-5. doi: 10.1016/j.bmcl.2012.07.079. Epub 2012 Jul 31.
8
Novel 4-arylaminoquinazoline derivatives with (E)-propen-1-yl moiety as potent EGFR inhibitors with enhanced antiproliferative activities against tumor cells.具有(E)-丙烯-1-基部分的新型4-芳基氨基喹唑啉衍生物作为有效的表皮生长因子受体(EGFR)抑制剂,对肿瘤细胞具有增强的抗增殖活性。
Eur J Med Chem. 2017 Sep 29;138:689-697. doi: 10.1016/j.ejmech.2017.06.023. Epub 2017 Jun 13.
9
Novel quinazoline derivatives bearing various 6-benzamide moieties as highly selective and potent EGFR inhibitors.新型喹唑啉衍生物,带有各种 6-苯甲酰胺取代基,作为高度选择性和有效的 EGFR 抑制剂。
Bioorg Med Chem. 2018 May 1;26(8):1740-1750. doi: 10.1016/j.bmc.2018.02.022. Epub 2018 Feb 16.
10
Facile and efficient synthesis and biological evaluation of 4-anilinoquinazoline derivatives as EGFR inhibitors.4-苯胺基喹唑啉衍生物作为表皮生长因子受体(EGFR)抑制剂的简便高效合成及生物学评价
Bioorg Med Chem Lett. 2016 Jun 1;26(11):2589-93. doi: 10.1016/j.bmcl.2016.04.032. Epub 2016 Apr 13.

引用本文的文献

1
Structure-Activity Relationship Studies Based on Quinazoline Derivatives as EGFR Kinase Inhibitors (2017-Present).基于喹唑啉衍生物作为表皮生长因子受体激酶抑制剂的构效关系研究(2017年至今)
Pharmaceuticals (Basel). 2023 Apr 3;16(4):534. doi: 10.3390/ph16040534.

本文引用的文献

1
Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.氟代 N,N-二烷基氨基二苯乙烯类化合物抑制 Wnt 通路和抑制结肠癌。
J Med Chem. 2011 Mar 10;54(5):1288-97. doi: 10.1021/jm101248v. Epub 2011 Feb 3.
2
Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.设计、合成及白藜芦醇类似物的生物评价作为芳香酶和醌还原酶 2 抑制剂用于癌症的化学预防。
Bioorg Med Chem. 2010 Jul 15;18(14):5352-66. doi: 10.1016/j.bmc.2010.05.042. Epub 2010 May 24.
3
Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.
肛门鳞状病变中生长因子受体的表达:与致癌性人乳头瘤病毒和人类免疫缺陷病毒相关的改变
Hum Pathol. 2009 Nov;40(11):1517-27. doi: 10.1016/j.humpath.2009.05.010. Epub 2009 Aug 27.
4
The design, synthesis, and anti-tumor mechanism study of N-phosphoryl amino acid modified resveratrol analogues.N-磷酰基氨基酸修饰白藜芦醇类似物的设计、合成及抗肿瘤机制研究
Bioorg Med Chem. 2008 Dec 1;16(23):10013-21. doi: 10.1016/j.bmc.2008.10.022. Epub 2008 Oct 12.
5
Protein tyrosine phosphatase-1B (PTP1B) helps regulate EGF-induced stimulation of S-phase entry in human corneal endothelial cells.蛋白酪氨酸磷酸酶-1B(PTP1B)有助于调节表皮生长因子(EGF)诱导的人角膜内皮细胞进入S期的刺激过程。
Mol Vis. 2008 Jan 16;14:61-70.
6
Lapatinib in the treatment of breast cancer.拉帕替尼在乳腺癌治疗中的应用。
Expert Rev Anticancer Ther. 2007 Sep;7(9):1183-92. doi: 10.1586/14737140.7.9.1183.
7
ErbB receptors: from oncogenes to targeted cancer therapies.表皮生长因子受体:从癌基因到癌症靶向治疗
J Clin Invest. 2007 Aug;117(8):2051-8. doi: 10.1172/JCI32278.
8
Quinone reductase induction activity of methoxylated analogues of resveratrol.白藜芦醇甲氧基类似物的醌还原酶诱导活性。
Eur J Med Chem. 2007 Jun;42(6):841-50. doi: 10.1016/j.ejmech.2006.12.012. Epub 2007 Jan 9.
9
Therapeutic potential of resveratrol: the in vivo evidence.白藜芦醇的治疗潜力:体内证据
Nat Rev Drug Discov. 2006 Jun;5(6):493-506. doi: 10.1038/nrd2060. Epub 2006 May 26.
10
A comprehensive pathway map of epidermal growth factor receptor signaling.表皮生长因子受体信号传导的综合通路图。
Mol Syst Biol. 2005;1:2005.0010. doi: 10.1038/msb4100014. Epub 2005 May 25.